1. Home
  2. IMUX vs OPTT Comparison

IMUX vs OPTT Comparison

Compare IMUX & OPTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMUX
  • OPTT
  • Stock Information
  • Founded
  • IMUX 2016
  • OPTT 1984
  • Country
  • IMUX United States
  • OPTT United States
  • Employees
  • IMUX N/A
  • OPTT 43
  • Industry
  • IMUX Biotechnology: Pharmaceutical Preparations
  • OPTT Electric Utilities: Central
  • Sector
  • IMUX Health Care
  • OPTT Utilities
  • Exchange
  • IMUX Nasdaq
  • OPTT Nasdaq
  • Market Cap
  • IMUX 67.1M
  • OPTT 89.7M
  • IPO Year
  • IMUX N/A
  • OPTT 2007
  • Fundamental
  • Price
  • IMUX $0.72
  • OPTT $0.51
  • Analyst Decision
  • IMUX Strong Buy
  • OPTT
  • Analyst Count
  • IMUX 6
  • OPTT 0
  • Target Price
  • IMUX $11.60
  • OPTT N/A
  • AVG Volume (30 Days)
  • IMUX 2.4M
  • OPTT 3.8M
  • Earning Date
  • IMUX 08-07-2025
  • OPTT 07-24-2025
  • Dividend Yield
  • IMUX N/A
  • OPTT N/A
  • EPS Growth
  • IMUX N/A
  • OPTT N/A
  • EPS
  • IMUX N/A
  • OPTT N/A
  • Revenue
  • IMUX N/A
  • OPTT $6,117,000.00
  • Revenue This Year
  • IMUX N/A
  • OPTT N/A
  • Revenue Next Year
  • IMUX N/A
  • OPTT N/A
  • P/E Ratio
  • IMUX N/A
  • OPTT N/A
  • Revenue Growth
  • IMUX N/A
  • OPTT 24.00
  • 52 Week Low
  • IMUX $0.56
  • OPTT $0.12
  • 52 Week High
  • IMUX $2.11
  • OPTT $1.75
  • Technical
  • Relative Strength Index (RSI)
  • IMUX 36.47
  • OPTT 51.52
  • Support Level
  • IMUX $0.71
  • OPTT $0.51
  • Resistance Level
  • IMUX $0.91
  • OPTT $0.61
  • Average True Range (ATR)
  • IMUX 0.07
  • OPTT 0.04
  • MACD
  • IMUX 0.00
  • OPTT -0.00
  • Stochastic Oscillator
  • IMUX 29.20
  • OPTT 44.29

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

About OPTT Ocean Power Technologies Inc.

Ocean Power Technologies Inc provides intelligent maritime solutions and services that enable safer, cleaner, and more productive ocean operations for the defense and security, oil and gas, science and research, and offshore wind markets. It provides ocean data collection and reporting, marine power, offshore communications, and Maritime Domain Awareness System (MDAS) products, integrated solutions, and consulting services. The company offers its products and services to a wide range of customers, including those in government and offshore energy, oil and gas, construction, wind power, and other industries. The company has operations in North and South America, Europe, Asia and Australia.

Share on Social Networks: